Israeli Company's Device Detects COVID-19 in 20 Seconds
Virusight Diagnostic, an Israeli company that combines artificial intelligence software and spectral technology, announced the results of a study that found its Pathogens Diagnostic device detects COVID-19 with 96.3% accuracy in comparison to the common RT-PCR (reverse transcription-polymerase chain reaction) test.
The study was conducted by researchers from the Department of Science and Technology, University of Sannio, Benevento, Italy, with partner company TechnoGenetics SpA.
Virusight is a collaboration between Tel Hashomer’s Sheba Medical Center ARC Innovation Center and Newsight Imaging, a company that develops CMOS (complementary metal-oxide-semiconductor) image sensor chips used in cameras and mobile devices.
Virusight’s SpectraLIT device obtains spectral signatures of the samples from mouth swabs and analyzes machine-learning algorithms that identify SARS-CoV-2. The device then sends the results to a phone or computer in 20 seconds.
The Virusight device is registered as an approved in vitro diagnostic (IVD) device. It has the CE mark for the European market and is pending regulatory approval in the United States, The United Kingdom, Latin America, and the Asia Pacific. It will be available in Europe in the coming weeks, according to the company. (JPost/ VFI News)
“Lord, we thank you for this innovative device and we ask that you continue to bring Israeli innovation to the forefront in the world, and heal this world from sickness, including Covid-19.”
The suggestions, opinions, and scripture references made by VFI News writers and editors are based on the best information received.
Want to see more from VFI? Follow us on Facebook! Our official Facebook name is Vision for Israel. Follow us there and please hit “like” if you like us.